Address: Beijing's xizhimen south street, xicheng district
The British garden 1 floor. Room 824
Zip code: 100035
Telephone: 010-58562339
Fax: 010-58562339
Email address: cngjzj@163.com
Web site (click on the url link directly left) :
http://www.cngjzj.com/
Blog (click on the url link directly left) :
http://blog.sina.com.Cn/CNGJZJ
To xizhimen south street, xicheng district building to the British garden route
L airport line 1
Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.
L airport line 2
From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.
L bus subway near:
106 bus GuanYuan: 107 road, express way
Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road
Che zhuang: subway line two
Xizhimen subway: metro line 2
Buses and attempts: 107 road, 118 road, 701 road
Buses and north zhuang: 209 road, 375 road, 392 road
2015年11月18日
Foreign media: traditional Chinese medicine (TCM) are usually cheaper than western medicine In rural China more popular
Time: 2015-11-17
Source: reference news network
Reference news network reported on November 13 Foreign media said that after 2000 years of practice and decades of scientific research, in China this year because of a derived from traditional Chinese medicine has found that won the Nobel Prize.
According to England "financial times" web site on November 13, tu due to find antimalarial drug artemisinin was awarded the Nobel Prize, the award in her, and said: "artemisinin is a traditional Chinese medicine the gift to the people of the world."
Now China across the private and public sector tens of thousands of researchers are continue to try to copy her success, try to simplify those by traditional Chinese medicine practitioners prescribe prescription for the treatment of complex and hard to understand and hard to implement, in order to obtain to sales of products on a global scale.
The Chinese government has made traditional Chinese medicine as its new innovation driven a pillar of the economic growth mode, a large number of investment in the field and use the national health care plan supports the use of traditional Chinese medicine. Traditional Chinese medicine (TCM) are usually cheaper than innovative western medicine, in most of China's population still lives in rural areas tend to be more popular.
China's growing middle class also prefer Chinese medicine on culture, and they sometimes more and have the ability to pay inflated cost of treatment, therefore the Chinese government to domestic consumers and businesses as any traditional Chinese medicine "gifts" from the first beneficiary in the future.
According to the report, although a lot of work, but there are few new blockbuster varieties of traditional Chinese medicines, and still no one can match the importance of artemisinin.
Shanghai innovation giave countries said deputy director of the centre for the study of Chinese medicine, Chinese scientists are using various methods to test the scientific basis of traditional Chinese medicine, make them easier to commercialization.
The total scale of traditional Chinese medicine industry is hard to gauge, because many of the traditional Chinese medicine (TCM) is a open a mixture of Chinese herbal medicine for individual patients. But the consulting company IMS Health estimates of big hospital in China, the scale of the traditional Chinese medicine formula particles industry from 87 billion yuan in 2012, growth in 2014 to RMB 116 billion (the industry to modernization of Chinese herbal medicine made from water soluble granules, convenient taking). Part of traditional Chinese medicine enterprises are listed, including listed in Hong Kong, state-owned China Chinese medicine co., LTD., and yunnan baiyao group listed in shenzhen.
Pharmaceutical industry consultant in Hong Kong with Jason, said: "these companies targeting the China is a growing middle class."
According to the report, prof ye said, it is unclear how Chinese medicine therapy in patients with western appeal, but "with its population making up a quarter of the world's population, if we can solve the problems of the Chinese people, has made great contribution to solve global problems".